Munafa Stock Market Course + Intraday & FNO calls 
Crispr Therapeutics (CRSP) Technical (Analysis) Reports Crispr Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Crispr Therapeutics (CRSP)
Technical Analysis Report for NASDAQ stock CRSP Crispr Therapeutics. Dated: 04 May 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock CRSP Crispr Therapeutics then click here. or read Experts views on Crispr Therapeutics or Forecast & share price targets of Crispr Therapeutics
Crispr Therapeutics Opened at 51.77 and Closed at: 53.58, which is 3.64% of previous session's close. It moved within a range of 51.77 and 54.41
The session was a Bullish session with an average volume of 1711700, which is 39.49% of previous session's volumes.
- The stock has shown an up move, and its short term trend is also positive and in an uptrend.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
A Dead cross was found 2 days back on short term averages
Support for tomorrow is 52.68 and resistance for tomorrow is 55.32
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 52.1, 50.61 resistance for tomorrow's hourly charts is 54.74, 55.89
10 Day SMA for Crispr Therapeutics (CRSP) is 52.72 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Crispr Therapeutics (CRSP) is 53.57 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Crispr Therapeutics (CRSP) is 52.59 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 53.34 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Crispr Therapeutics is 56.44 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Crispr Therapeutics is at 53.57 and 200 DMA is at 56.44, while 50 DMA and 100 DMA are at 52.59 and 53.34 respectively
Crispr Therapeutics (CRSP) moving average of 20 SMA is at 53.57 and 20 EMA is at 52.67
| Date | Closing Price | 20 SMA | 20 EMA |
| 04 Mon May | 53.58 | 53.57 | 52.67 |
| 01 Fri May | 51.63 | 53.35 | 52.57 |
| 30 Thu Apr | 52.34 | 53.24 | 52.67 |
| 29 Wed Apr | 50.71 | 53.07 | 52.71 |
| 28 Tue Apr | 52.06 | 52.91 | 52.92 |
| 27 Mon Apr | 50.99 | 52.52 | 53.01 |
Crispr Therapeutics (CRSP) moving average of 50 SMA is at 52.59 and 50 EMA is at 52.58
| Date | Closing Price | 50 SMA | 50 EMA |
| 04 Mon May | 53.58 | 52.59 | 52.58 |
| 01 Fri May | 51.63 | 52.61 | 52.54 |
| 30 Thu Apr | 52.34 | 52.65 | 52.58 |
| 29 Wed Apr | 50.71 | 52.66 | 52.59 |
| 28 Tue Apr | 52.06 | 52.71 | 52.67 |
| 27 Mon Apr | 50.99 | 52.73 | 52.69 |
Crispr Therapeutics (CRSP) moving average of 100 SMA is at 53.34 and 100 EMA is at 53.28
| Date | Closing Price | 100 SMA | 100 EMA |
| 04 Mon May | 53.58 | 53.34 | 53.28 |
| 01 Fri May | 51.63 | 53.38 | 53.27 |
| 30 Thu Apr | 52.34 | 53.43 | 53.3 |
| 29 Wed Apr | 50.71 | 53.49 | 53.32 |
| 28 Tue Apr | 52.06 | 53.54 | 53.37 |
| 27 Mon Apr | 50.99 | 53.54 | 53.4 |
Crispr Therapeutics (CRSP) moving average of 200 SMA is at 56.44 and 200 EMA is at 53.17
| Date | Closing Price | 200 SMA | 200 EMA |
| 04 Mon May | 53.58 | 56.44 | 53.17 |
| 01 Fri May | 51.63 | 56.45 | 53.17 |
| 30 Thu Apr | 52.34 | 56.47 | 53.19 |
| 29 Wed Apr | 50.71 | 56.47 | 53.2 |
| 28 Tue Apr | 52.06 | 56.5 | 53.23 |
| 27 Mon Apr | 50.99 | 56.52 | 53.24 |
Xoma Corporation has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Xoma Corporation, about 10.87% more returns!
Staar Surgical has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Staar Surgical, about 21.59% more returns!
Crispr Therapeutics has performed better than Syndax Pharmaceuticals in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics has performed better than Soleno Therapeutics in short term. Holding Crispr Therapeutics could be a better choice for now!
Surgery Partners has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Surgery Partners, about 4.44% more returns!
Crispr Therapeutics has performed better than Repligen Corporation in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics has performed better than Prothena Corporation in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics has performed better than Pulse Biosciences in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics has performed better than Intellia Therapeutics in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics has performed better than Liquidia Technologies in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics has performed better than Acadia Pharmaceuticals in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics has performed better than Addus Homecare in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics has performed better than Ani Pharmaceuticals in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics has performed better than Ascendis Pharma in short term. Holding Crispr Therapeutics could be a better choice for now!
Axsome Therapeutics has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Axsome Therapeutics, about 24.76% more returns!
Crispr Therapeutics has performed better than Collegium Pharmaceutical in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics has performed better than Cytokinetics Incorporated in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics has performed better than Fonar Corporation in short term. Holding Crispr Therapeutics could be a better choice for now!
Healthways Inc has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Healthways Inc, about 2.22% more returns!
Crispr Therapeutics Technical analysis of indicators
Price action analysis of Crispr Therapeutics (CRSP) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Crispr Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Crispr Therapeutics in short term but the sell signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Crispr Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Crispr Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Crispr Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 52.52 and Crispr Therapeutics CRSP stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Crispr Therapeutics CRSP stock. Volume based technical analysis of Crispr Therapeutics CRSP stock is negative.
Crispr Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock CRSP Crispr Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And CRSP Experts View which covers a lot of information including buying and selling signals
CRSP future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Crispr Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Crispr Therapeutics (CRSP) Technical (Analysis) Reports Crispr Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
